Trade

with

Echo Therapeutics Inc
(NASDAQ: ECTE)
AdChoices
0.7200
+0.0301
+4.36%
After Hours :
0.6900
-0.0300
-4.17%

Open

0.7050

Previous Close

0.6899

Volume (Avg)

8.71k (100.70k)

Day's Range

0.6800-0.7200

52Wk Range

0.3900-4.91

Market Cap.

8.74M

Dividend Rate ( Yield )

-

Beta

1.27

Shares Outstanding

12.67M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Major
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 27.60k

    • Net Income

    • -19.07M

    • Market Cap.

    • 8.74M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -75,583.73

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.27

    • Forward P/E

    • -

    • Price/Sales

    • 384.62

    • Price/Book Value

    • 0.56

    • Price/Cash flow

    • -0.55

      • EBITDA

      • -14.78M

      • Return on Capital %

      • -67.73

      • Return on Equity %

      • -81.39

      • Return on Assets %

      • -67.73

      • Book Value/Share

      • 1.24

      • Shares Outstanding

      • 12.67M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -15.30

          • 0.89

          • Net Income

            YTD/YTD (last year)

          • -

          • 7.80

          • Net Income

            Q/Q (last year)

          • -

          • 4.50

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 6.10

          • Net Income

            5-Year Annual Average

          • -

          • 3.73

          • Dividends

            5-Year Annual Average

          • -

          • 2.17

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 100.00

            • 69.92

            • Pre-Tax Margin

            • -73,790.78

            • 21.84

            • Net Profit Margin

            • -75,583.73

            • 18.37

            • Average Gross Margin

              5-Year Annual Average

            • 100.00

            • 71.90

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 21.92

            • Average Net Profit Margin

              5-Year Annual Average

            • -63,417.70

            • 903.40B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.32

              • Current Ratio

              • 2.07

              • 1.92

              • Quick Ratio

              • 1.59

              • 1.31

              • Interest Coverage

              • -14.73

              • 17.64

              • Leverage Ratio

              • 1.17

              • 2.03

              • Book Value/Share

              • 1.24

              • 14.62

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -0.54

                • 22.62

                • P/E Ratio 5-Year High

                • -36.12

                • 193.96

                • P/E Ratio 5-Year Low

                • -0.28

                • 87.26

                • Price/Sales Ratio

                • 400.00

                • 3.79

                • Price/Book Value

                • 0.60

                • 3.78

                • Price/Cash Flow Ratio

                • -0.55

                • 14.31

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -81.39

                    (-121.20)

                  • 17.42

                    (18.66)

                  • Return on Assets %

                    (5-Year Average)

                  • -67.73

                    (-84.20)

                  • 8.45

                    (8.77)

                  • Return on Capital %

                    (5-Year Average)

                  • -76.33

                    (-122.50)

                  • 12.41

                    (13.18)

                  • Income/Employee

                  • -

                  • 90.07k

                  • Inventory Turnover

                  • -

                  • 2.46

                  • Asset Turnover

                  • 0.00

                  • 0.46

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -19.64M
                  Operating Margin
                  -71,146.62
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -0.55
                  Ownership

                  Institutional Ownership

                  34.02%

                  Top 10 Institutions

                  33.23%

                  Mutual Fund Ownership

                  2.28%

                  Float

                  80.47%

                  5% / Insider Ownership

                  47.74%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Total Stock Mkt Idx

                  •  

                    168,231

                  • 0.00

                  • 1.33

                  • Vanguard Extended Market Index Fund

                  •  

                    62,574

                  • 53.47

                  • 0.49

                  • Perkins Discovery Fund

                  •  

                    22,500

                  • 0.00

                  • 0.18

                  • Fidelity Spartan® Extended Mkt Indx Fd

                  •  

                    18,765

                  • 0.00

                  • 0.15

                  • Americio SICAV

                  •  

                    10,007

                  • -0.02

                  • 0.08

                  • Master Extended Market Index Series

                  •  

                    2,662

                  • 0.00

                  • 0.02

                  • USAA Extended Market Index Fund

                  •  

                    2,661

                  • -0.04

                  • 0.02

                  • Fidelity Spartan® Total Market Idx Fund

                  •  

                    2,009

                  • 0.00

                  • 0.02

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Platinum Management (ny) Llc

                  •  

                    1,605,424

                  • 0.00%

                  • 12.67

                  • Nomura Holdings Inc

                  •  

                    750,000

                  • +247.54%

                  • 5.70

                  • Platinum Liquid Opportunity Management (NY) LLC

                  •  

                    678,452

                  • 0.00%

                  • 5.35

                  • Vanguard Group, Inc.

                  •  

                    209,005

                  • +0.14%

                  • 1.65

                  • Knoll Capital Management LP

                  •  

                    27,430

                  • -4.19%

                  • 0.22

                  • Geduld E E

                  •  

                    25,000

                  • -50.00%

                  • 0.20

                  • Perkins Capital Management Inc

                  •  

                    22,500

                  • 0.00%

                  • 0.18

                  • National Planning Corporation

                  •  

                    22,250

                  • -3.68%

                  • 0.17

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Major

                  Type

                  Distressed

                  Style

                  Small Core

                  Echo Therapeutics Inc was incorporated in Delaware in September 2007 under the name Durham Pharmaceuticals Acquisition Co. It is a medical device company with expertise in advanced skin permeation technology. The Companys medical dev...moreice program is Symphony, a non-invasive, wireless, continuous glucose monitoring system designed to provide reliable, real-time glucose data conveniently, continuously and cost-effectively. The Symphony CGM System incorporates its SkinPrep device, transdermal glucose sensor, wireless transmitter and data display monitor. It is developing its Prelude SkinPrep System as a platform technology to allow for enhanced skin permeation that will enable two important applications; analyte extraction and needle-free drug delivery. It currently has two key strategic partnerships in ...moreplace. It has granted Ferndale Pharma Group, Inc. a license to develop, market and sell the Prelude device for enhanced and needle-free delivery of topical anesthetics prior to needle insertion. It has also granted Handok Pharmaceuticals Co., Ltd. a license to develop, market and sell the Symphony CGM System for continuous glucose monitoring in South Korea. The Company competes with Edwards Lifesciences Corporation, Optiscan Biomedical Corp., Maquet Critical Care AB, Medtronic, Inc. A. Menarini Diagnostics S.r.l., Roche, Johnson & Johnson, Bayer and Abbott Laboratories. Government authorities in the United States, at the federal, state and local level, the European Union, and other countries extensively regulate the research, development, testing, manufacture, labeling, promotion, advertising, distribution, marketing, export and import of products such as those the Company are developing.lessless

                  Key People

                  Kimberly A. Burke

                  CEO/General Counsel/Other Executive Officer/Senior VP

                  Charles T. Bernhardt

                  CFO

                  Dr. Michael M. Goldberg,M.D.

                  Director

                  Mr. William F. Grieco

                  Director

                  Mr. Vincent D. Enright

                  Director

                  • Echo Therapeutics Inc

                  • 8 Penn Center, 1628 JFK Boulevard

                  • Philadelphia, PA 19103

                  • USA.Map

                  • Phone: +1 215 717-4100

                  • Fax: -

                  • echotx.com

                  Incorporated

                  2007

                  Employees

                  29

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: